Centamin Egypt Limited
26 May 2006
Centamin Egypt Limited
('Centamin Egypt' or 'the Company')
Issue of Equity and director's shareholding
The Company announces that, on 26 May 2006, 250,000 options were exercised under
the Employee Share Option Plan 2002 at an exercise price of A$0.3549 per share
by Mr. Colin N. Cowden, a director of the Company. Following this exercise, Mr.
Cowden's holdings in the Company's shares are as follows:
Registered holder No. of shares
Black Cat Holdings Pty Ltd* 400,597
Mr. C. N. Cowden 92,833
Cowden Limited** 29,596
* Mr. Cowden owns 50% of the shares
** Mr. Cowden owns 33.08% of the shares
Application has been made for the new ordinary shares to be admitted to trading
on the AIM Market of the London Stock Exchange ('AIM'). The new ordinary shares
will rank pari passu with the existing ordinary shares in the Company and
trading of these shares on AIM is expected to commence on 1 June 2006.
The total number of ordinary shares in issue following this issue is
578,295,369.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.